Regeneron Pharmaceuticals
REGN
#296
Rank
โ‚น7.410 T
Marketcap
โ‚น70,094
Share price
-1.72%
Change (1 day)
14.09%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2025 (TTM): โ‚น457.86 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are โ‚น14.34 Billion. , an increase over its 2024 earnings that were of โ‚น434.67 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น475.66 B9.43%
2024 โ‚น434.67 B13.83%
2023 โ‚น381.87 B-13.57%
2022 โ‚น441.84 B-47.9%
2021 โ‚น848.06 B144.75%
2020 โ‚น346.50 B56.86%
2019 โ‚น220.89 B-4.87%
2018 โ‚น232.21 B22.86%
2017 โ‚น189.01 B56.3%
2016 โ‚น120.93 B8.55%
2015 โ‚น111.40 B54.53%
2014 โ‚น72.09 B11.14%
2013 โ‚น64.87 B72.13%
2012 โ‚น37.68 B-285.93%
2011 -โ‚น20.27 Billion121.73%
2010 -โ‚น9.15 Billion37.18%
2009 -โ‚น6.67 Billion-14.6%
2008 -โ‚น7.81 Billion-25.02%
2007 -โ‚น10.41 Billion6.32%
2006 -โ‚น9.79 Billion-186.52%
2005 โ‚น11.31 B2103.7%
2004 โ‚น0.51 B-105.66%
2003 -โ‚น9.08 Billion-18.18%
2002 -โ‚น11.1 Billion42.33%
2001 -โ‚น7.8 Billion129.35%
2000 -โ‚น3.4 Billion51.87%
1999 -โ‚น2.24 Billion92.19%
1998 -โ‚น1.17 Billion66.23%
1997 -โ‚น0.71 Billion-55.49%
1996 -โ‚น1.58 Billion103.53%
1995 -โ‚น0.78 Billion-70.89%
1994 -โ‚น2.66 Billion-26.08%
1993 -โ‚น3.6 Billion114.67%
1992 -โ‚น1.68 Billion196.77%
1991 -โ‚น0.57 Billion87.88%
1990 -โ‚น0.31 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.946 T 519.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.487 T 212.62%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
โ‚น749.68 B 57.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น827.55 B 73.98%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚น173.14 B-63.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น11.85 B-97.51%๐Ÿ‡บ๐Ÿ‡ธ USA